AstraZeneca Pharmaceuticals LP
Summary
- Total Recalls
- 6 (1 Class I)
- 510(k) Clearances
- 0
- Inspections
- 61
- Compliance Actions
- 1
Known Names
astrazeneca pharmaceuticals, astrazeneca pharmaceuticals co
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0028-2026 | Class II | Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufacture | October 8, 2025 |
| D-0585-2018 | Class III | Lynparza (olaparib) capsules 50 mg, 112 count bottles, Rx only, Manufactured for: Astra Zeneca Pharm | February 23, 2018 |
| D-0958-2017 | Class I | BRILINTA (ticagrelor) tablets, 90 mg, 8-count Professional Sample bottles, Rx only, Mfd. for: AstraZ | May 25, 2017 |
| D-0781-2016 | Class II | Tudorza Pressair (aclindinium bromide inhalation powder), 400 mcg per actuation, 60 Metered Doses pe | February 5, 2016 |
| D-1141-2015 | Class II | NEXIUM¿ (esomeprazole magnesium), Delayed-Release capsules, 20 mg, 30-count bottle, Rx only, Manufac | June 10, 2015 |
| D-840-2013 | Class II | MERREM I.V. (meropenem for injection), 1 g meropenem equivalent, 30 mL vial, Rx only, Mfd for: Astra | June 21, 2013 |